Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.

Saved in:
Bibliographic Details
Title: Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.
Authors: Durier C; INSERM US19, Villejuif, France. Electronic address: christine.durier@inserm.fr., Ninove L; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., van der Werf S; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France., Lefebvre M; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France., Desaint C; INSERM US19, Villejuif, France; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Bauer R; INSERM US19, Villejuif, France., Attia M; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France., Lecompte AS; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France., Lachatre M; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Maakaroun-Vermesse Z; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France., Nicolas JF; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France; CHU Lyon-Sud, Pierre-Bénite, France., Verdon R; Service de Maladies Infectieuses, CHU de Caen, Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France., Kiladjian JJ; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France., Loubet P; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Montpellier, France., Schmidt-Mutter C; INSERM CIC 1434, CHU Strasbourg, Strasbourg, France., Corbin V; CHU Clermont-Ferrand, INSERM CIC1405, Clermont-Ferrand, France., Ansart S; INSERM CIC 1412, CHU Brest, Brest, France., Melica G; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, INSERM CIC 1430, Créteil, France., Resch M; INSERM US19, Villejuif, France., Netzer E; INSERM US19, Villejuif, France., Kherabi Y; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Tardieu R; ANRS Emerging Infectious Diseases, Paris, France., Lelièvre JD; INSERM U955, Vaccine Research Institute, Créteil, France., Tartour E; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France., Meyer L; INSERM US19, Villejuif, France; INSERM, CESP U1018, Université Paris Saclay, APHP, Le Kremlin-Bicêtre, France., de Lamballerie X; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Launay O; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.
Corporate Authors: ANRS002S CoviCompareP group
Source: Infectious diseases now [Infect Dis Now] 2024 Aug; Vol. 54 (5), pp. 104886. Date of Electronic Publication: 2024 Mar 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Masson Country of Publication: France NLM ID: 101775152 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-9919 (Electronic) Linking ISSN: 26669919 NLM ISO Abbreviation: Infect Dis Now Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38494117
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Durier+C%22">Durier C</searchLink>; INSERM US19, Villejuif, France. Electronic address: christine.durier@inserm.fr.<br /><searchLink fieldCode="AU" term="%22Ninove+L%22">Ninove L</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22van+der+Werf+S%22">van der Werf S</searchLink>; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lefebvre+M%22">Lefebvre M</searchLink>; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Desaint+C%22">Desaint C</searchLink>; INSERM US19, Villejuif, France; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bauer+R%22">Bauer R</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Attia+M%22">Attia M</searchLink>; Institut Pasteur, Université Paris Cité, UMR 3569 CNRS, Unité de Génétique Moléculaire des Virus à ARN, Centre National de Référence Virus des Infections Respiratoires, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lecompte+AS%22">Lecompte AS</searchLink>; Service de maladies infectieuses et tropicales, Centre de prévention des maladies infectieuses et transmissibles CHU de Nantes - CIC1413 Nantes, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Lachatre+M%22">Lachatre M</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Maakaroun-Vermesse+Z%22">Maakaroun-Vermesse Z</searchLink>; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France.<br /><searchLink fieldCode="AU" term="%22Nicolas+JF%22">Nicolas JF</searchLink>; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France; CHU Lyon-Sud, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Verdon+R%22">Verdon R</searchLink>; Service de Maladies Infectieuses, CHU de Caen, Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France.<br /><searchLink fieldCode="AU" term="%22Kiladjian+JJ%22">Kiladjian JJ</searchLink>; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Loubet+P%22">Loubet P</searchLink>; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Schmidt-Mutter+C%22">Schmidt-Mutter C</searchLink>; INSERM CIC 1434, CHU Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Corbin+V%22">Corbin V</searchLink>; CHU Clermont-Ferrand, INSERM CIC1405, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Ansart+S%22">Ansart S</searchLink>; INSERM CIC 1412, CHU Brest, Brest, France.<br /><searchLink fieldCode="AU" term="%22Melica+G%22">Melica G</searchLink>; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, INSERM CIC 1430, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Resch+M%22">Resch M</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Netzer+E%22">Netzer E</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Kherabi+Y%22">Kherabi Y</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Tardieu+R%22">Tardieu R</searchLink>; ANRS Emerging Infectious Diseases, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lelièvre+JD%22">Lelièvre JD</searchLink>; INSERM U955, Vaccine Research Institute, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Tartour+E%22">Tartour E</searchLink>; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Meyer+L%22">Meyer L</searchLink>; INSERM US19, Villejuif, France; INSERM, CESP U1018, Université Paris Saclay, APHP, Le Kremlin-Bicêtre, France.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Launay+O%22">Launay O</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ANRS002S+CoviCompareP+group%22">ANRS002S CoviCompareP group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101775152%22">Infectious diseases now</searchLink> [Infect Dis Now] 2024 Aug; Vol. 54 (5), pp. 104886. <i>Date of Electronic Publication: </i>2024 Mar 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Masson%22">Elsevier Masson </searchLink><i>Country of Publication: </i>France <i>NLM ID: </i>101775152 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-9919 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226669919%22">26669919 </searchLink><i>NLM ISO Abbreviation: </i>Infect Dis Now <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38494117
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.idnow.2024.104886
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 104886
    Titles:
      – TitleFull: Incidence of COVID-19 mRNA vaccine symptomatic breakthrough infections during Omicron circulation in adults with or without infection prior to vaccination.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Durier C
      – PersonEntity:
          Name:
            NameFull: Ninove L
      – PersonEntity:
          Name:
            NameFull: van der Werf S
      – PersonEntity:
          Name:
            NameFull: Lefebvre M
      – PersonEntity:
          Name:
            NameFull: Desaint C
      – PersonEntity:
          Name:
            NameFull: Bauer R
      – PersonEntity:
          Name:
            NameFull: Attia M
      – PersonEntity:
          Name:
            NameFull: Lecompte AS
      – PersonEntity:
          Name:
            NameFull: Lachatre M
      – PersonEntity:
          Name:
            NameFull: Maakaroun-Vermesse Z
      – PersonEntity:
          Name:
            NameFull: Nicolas JF
      – PersonEntity:
          Name:
            NameFull: Verdon R
      – PersonEntity:
          Name:
            NameFull: Kiladjian JJ
      – PersonEntity:
          Name:
            NameFull: Loubet P
      – PersonEntity:
          Name:
            NameFull: Schmidt-Mutter C
      – PersonEntity:
          Name:
            NameFull: Corbin V
      – PersonEntity:
          Name:
            NameFull: Ansart S
      – PersonEntity:
          Name:
            NameFull: Melica G
      – PersonEntity:
          Name:
            NameFull: Resch M
      – PersonEntity:
          Name:
            NameFull: Netzer E
      – PersonEntity:
          Name:
            NameFull: Kherabi Y
      – PersonEntity:
          Name:
            NameFull: Tardieu R
      – PersonEntity:
          Name:
            NameFull: Lelièvre JD
      – PersonEntity:
          Name:
            NameFull: Tartour E
      – PersonEntity:
          Name:
            NameFull: Meyer L
      – PersonEntity:
          Name:
            NameFull: de Lamballerie X
      – PersonEntity:
          Name:
            NameFull: Launay O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2024 Aug
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2666-9919
          Numbering:
            – Type: volume
              Value: 54
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Infectious diseases now
              Type: main
ResultId 1